申请人:IRM LLC
公开号:US07820705B2
公开(公告)日:2010-10-26
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPAR.
本发明提供了化合物,包括这些化合物的药物组合物以及使用这些化合物来治疗或预防与过氧化物酶体增殖物激活受体(PPAR)家族的活性相关的疾病或疾病的方法,特别是与PPAR的活性相关的疾病或疾病。